Donor-recipient human leukocyte antigen matching practices in vascularized composite tissue allotransplantation: a survey of major transplantation centers.

Tamara Ashvetiya, Gerhard S. Mundinger, Debra Kukuruga, Branko Bojovic, Michael R. Christy, Amir Dorafshar, Eduardo D. Rodriguez

Research output: Contribution to journalArticle

Abstract

Vascularized composite tissue allotransplant recipients are often highly sensitized to human leukocyte antigens because of multiple prior blood transfusions and other reconstructive operations. The use of peripheral blood obtained from dead donors for crossmatching may be insufficient because of life support measures taken for the donor before donation. No study has been published investigating human leukocyte antigen matching practices in this field. A survey addressing human leukocyte antigen crossmatching methods was generated and sent to 22 vascularized composite tissue allotransplantation centers with active protocols worldwide. Results were compiled by center and compared using two-tailed t tests. Twenty of 22 centers (91 percent) responded to the survey. Peripheral blood was the most commonly reported donor sample for vascularized composite tissue allotransplant crossmatching [78 percent of centers (n=14)], with only 22 percent (n=4) using lymph nodes. However, 56 percent of the 18 centers (n=10) that had performed vascularized composite tissue allotransplantation reported that they harvested lymph nodes for crossmatching. Of responding individuals, 62.5 percent (10 of 16 individuals) felt that lymph nodes were the best donor sample for crossmatching. A slight majority of vascularized composite tissue allotransplant centers that have performed clinical transplants have used lymph nodes for human leukocyte antigen matching, and centers appear to be divided on the utility of lymph node harvest. The use of lymph nodes may offer a number of potential benefits. This study highlights the need for institutional review board-approved crossmatching protocols specific to vascularized composite tissue allotransplantation, and the need for global databases for sharing of vascularized composite tissue allotransplantation experiences.

Original languageEnglish (US)
Pages (from-to)121-129
Number of pages9
JournalPlastic and Reconstructive Surgery
Volume134
Issue number1
StatePublished - 2014
Externally publishedYes

Fingerprint

Vascularized Composite Allotransplantation
HLA Antigens
Transplantation
Lymph Nodes
Histocompatibility Testing
Surveys and Questionnaires
Research Ethics Committees
Blood Transfusion
Databases
Transplants

ASJC Scopus subject areas

  • Surgery

Cite this

Ashvetiya, T., Mundinger, G. S., Kukuruga, D., Bojovic, B., Christy, M. R., Dorafshar, A., & Rodriguez, E. D. (2014). Donor-recipient human leukocyte antigen matching practices in vascularized composite tissue allotransplantation: a survey of major transplantation centers. Plastic and Reconstructive Surgery, 134(1), 121-129.

Donor-recipient human leukocyte antigen matching practices in vascularized composite tissue allotransplantation : a survey of major transplantation centers. / Ashvetiya, Tamara; Mundinger, Gerhard S.; Kukuruga, Debra; Bojovic, Branko; Christy, Michael R.; Dorafshar, Amir; Rodriguez, Eduardo D.

In: Plastic and Reconstructive Surgery, Vol. 134, No. 1, 2014, p. 121-129.

Research output: Contribution to journalArticle

Ashvetiya, T, Mundinger, GS, Kukuruga, D, Bojovic, B, Christy, MR, Dorafshar, A & Rodriguez, ED 2014, 'Donor-recipient human leukocyte antigen matching practices in vascularized composite tissue allotransplantation: a survey of major transplantation centers.', Plastic and Reconstructive Surgery, vol. 134, no. 1, pp. 121-129.
Ashvetiya, Tamara ; Mundinger, Gerhard S. ; Kukuruga, Debra ; Bojovic, Branko ; Christy, Michael R. ; Dorafshar, Amir ; Rodriguez, Eduardo D. / Donor-recipient human leukocyte antigen matching practices in vascularized composite tissue allotransplantation : a survey of major transplantation centers. In: Plastic and Reconstructive Surgery. 2014 ; Vol. 134, No. 1. pp. 121-129.
@article{976a6515934f41c49103984532eac7e2,
title = "Donor-recipient human leukocyte antigen matching practices in vascularized composite tissue allotransplantation: a survey of major transplantation centers.",
abstract = "Vascularized composite tissue allotransplant recipients are often highly sensitized to human leukocyte antigens because of multiple prior blood transfusions and other reconstructive operations. The use of peripheral blood obtained from dead donors for crossmatching may be insufficient because of life support measures taken for the donor before donation. No study has been published investigating human leukocyte antigen matching practices in this field. A survey addressing human leukocyte antigen crossmatching methods was generated and sent to 22 vascularized composite tissue allotransplantation centers with active protocols worldwide. Results were compiled by center and compared using two-tailed t tests. Twenty of 22 centers (91 percent) responded to the survey. Peripheral blood was the most commonly reported donor sample for vascularized composite tissue allotransplant crossmatching [78 percent of centers (n=14)], with only 22 percent (n=4) using lymph nodes. However, 56 percent of the 18 centers (n=10) that had performed vascularized composite tissue allotransplantation reported that they harvested lymph nodes for crossmatching. Of responding individuals, 62.5 percent (10 of 16 individuals) felt that lymph nodes were the best donor sample for crossmatching. A slight majority of vascularized composite tissue allotransplant centers that have performed clinical transplants have used lymph nodes for human leukocyte antigen matching, and centers appear to be divided on the utility of lymph node harvest. The use of lymph nodes may offer a number of potential benefits. This study highlights the need for institutional review board-approved crossmatching protocols specific to vascularized composite tissue allotransplantation, and the need for global databases for sharing of vascularized composite tissue allotransplantation experiences.",
author = "Tamara Ashvetiya and Mundinger, {Gerhard S.} and Debra Kukuruga and Branko Bojovic and Christy, {Michael R.} and Amir Dorafshar and Rodriguez, {Eduardo D.}",
year = "2014",
language = "English (US)",
volume = "134",
pages = "121--129",
journal = "Plastic and Reconstructive Surgery",
issn = "0032-1052",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Donor-recipient human leukocyte antigen matching practices in vascularized composite tissue allotransplantation

T2 - a survey of major transplantation centers.

AU - Ashvetiya, Tamara

AU - Mundinger, Gerhard S.

AU - Kukuruga, Debra

AU - Bojovic, Branko

AU - Christy, Michael R.

AU - Dorafshar, Amir

AU - Rodriguez, Eduardo D.

PY - 2014

Y1 - 2014

N2 - Vascularized composite tissue allotransplant recipients are often highly sensitized to human leukocyte antigens because of multiple prior blood transfusions and other reconstructive operations. The use of peripheral blood obtained from dead donors for crossmatching may be insufficient because of life support measures taken for the donor before donation. No study has been published investigating human leukocyte antigen matching practices in this field. A survey addressing human leukocyte antigen crossmatching methods was generated and sent to 22 vascularized composite tissue allotransplantation centers with active protocols worldwide. Results were compiled by center and compared using two-tailed t tests. Twenty of 22 centers (91 percent) responded to the survey. Peripheral blood was the most commonly reported donor sample for vascularized composite tissue allotransplant crossmatching [78 percent of centers (n=14)], with only 22 percent (n=4) using lymph nodes. However, 56 percent of the 18 centers (n=10) that had performed vascularized composite tissue allotransplantation reported that they harvested lymph nodes for crossmatching. Of responding individuals, 62.5 percent (10 of 16 individuals) felt that lymph nodes were the best donor sample for crossmatching. A slight majority of vascularized composite tissue allotransplant centers that have performed clinical transplants have used lymph nodes for human leukocyte antigen matching, and centers appear to be divided on the utility of lymph node harvest. The use of lymph nodes may offer a number of potential benefits. This study highlights the need for institutional review board-approved crossmatching protocols specific to vascularized composite tissue allotransplantation, and the need for global databases for sharing of vascularized composite tissue allotransplantation experiences.

AB - Vascularized composite tissue allotransplant recipients are often highly sensitized to human leukocyte antigens because of multiple prior blood transfusions and other reconstructive operations. The use of peripheral blood obtained from dead donors for crossmatching may be insufficient because of life support measures taken for the donor before donation. No study has been published investigating human leukocyte antigen matching practices in this field. A survey addressing human leukocyte antigen crossmatching methods was generated and sent to 22 vascularized composite tissue allotransplantation centers with active protocols worldwide. Results were compiled by center and compared using two-tailed t tests. Twenty of 22 centers (91 percent) responded to the survey. Peripheral blood was the most commonly reported donor sample for vascularized composite tissue allotransplant crossmatching [78 percent of centers (n=14)], with only 22 percent (n=4) using lymph nodes. However, 56 percent of the 18 centers (n=10) that had performed vascularized composite tissue allotransplantation reported that they harvested lymph nodes for crossmatching. Of responding individuals, 62.5 percent (10 of 16 individuals) felt that lymph nodes were the best donor sample for crossmatching. A slight majority of vascularized composite tissue allotransplant centers that have performed clinical transplants have used lymph nodes for human leukocyte antigen matching, and centers appear to be divided on the utility of lymph node harvest. The use of lymph nodes may offer a number of potential benefits. This study highlights the need for institutional review board-approved crossmatching protocols specific to vascularized composite tissue allotransplantation, and the need for global databases for sharing of vascularized composite tissue allotransplantation experiences.

UR - http://www.scopus.com/inward/record.url?scp=84900821899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900821899&partnerID=8YFLogxK

M3 - Article

C2 - 25028821

AN - SCOPUS:84900821899

VL - 134

SP - 121

EP - 129

JO - Plastic and Reconstructive Surgery

JF - Plastic and Reconstructive Surgery

SN - 0032-1052

IS - 1

ER -